Higher prenatal MEP (AOR = 0.69, 95% CI = 0.52–0.92, p = 0.01) and MiBP (AOR = 0.62, 95% CI = 0.41–0.95, p = 0.02) were associated with lower odds of eczema at 12 months; however, higher prenatal MCNP (AOR =1.25, 95% CI = 1.05–1.50, p = 0.01) and MBzP (AOR = 1.30, 95% CI = 1.00–1.69, p = 0.04) were associated with increased odds of eczema. The gene discussed is NMRK2; the disease is Eczematoid dermatitis.